Baxter Bros’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PGEN
Baxter Bros's PGEN Position: Q3 2017 in Review
Baxter Bros sold out of Precigen (PGEN) in Q3 2017, closing a stake of 9,590 shares — an estimated $231K sold.
Baxter Bros first reported a position in PGEN in Q2 2017 and held it in 1 quarter. The position peaked at $231K in Q2 2017. 155 funds tracked by Wall St. Rank hold PGEN as of Q3 2017.
- Baxter Bros reported no remaining Precigen position as of Q3 2017 after selling out during the quarter.
- Baxter Bros sold 9,590 Precigen shares in Q3 2017, an estimated $231K.
- Baxter Bros first reported a position in Precigen in Q2 2017 and held it in 1 quarter.
- Baxter Bros's Precigen position peaked at $231K in Q2 2017.
- 155 funds tracked by Wall St. Rank held Precigen as of Q3 2017.
Based on Baxter Bros's 13F filing for Q3 2017, filed 16 Oct 2017.